View Item 

Show simple item record

Do anti-leukotriene agents inhibit asthmatic inflammation?
dc.contributor.authorPeters-Golden, Marc L.en_US
dc.date.accessioned2010-06-01T22:32:50Z
dc.date.available2010-06-01T22:32:50Z
dc.date.issued2003-06en_US
dc.identifier.citationPeters-Golden, M. (2003). "Do anti-leukotriene agents inhibit asthmatic inflammation?." Clinical & Experimental Allergy 33(6): 721-724. <http://hdl.handle.net/2027.42/75529>en_US
dc.identifier.issn0954-7894en_US
dc.identifier.issn1365-2222en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/75529
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=12801303&dopt=citationen_US
dc.format.extent279687 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Science Ltden_US
dc.rightsBlackwell Publishing Ltd, 2003en_US
dc.titleDo anti-leukotriene agents inhibit asthmatic inflammation?en_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelMicrobiology and Immunologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDivision of Pulmonary and Critical Care Medicine University of Michigan Health System Ann Arbor, MichiganUSA E-mail: petersm@umich.eduen_US
dc.identifier.pmid12801303en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/75529/1/j.1365-2222.2003.01685.x.pdf
dc.identifier.doi10.1046/j.1365-2222.2003.01685.xen_US
dc.identifier.sourceClinical & Experimental Allergyen_US
dc.identifier.citedreferencePeters-Golden M, Sampson A. Cysteinyl leukotriene interactions with other mediators and with glucocorticoids during airway inflammation. J Allergy Clin Immunol 2003; 111: S37 – S48.en_US
dc.identifier.citedreferenceMancuso P, Gottschalk A, Phare S, Peters-Golden M, Lukacs N, Huffnagle G. Leptin-deficient mice exhibit impaired host defense in gram-negative pneumonia. J Immunol 2002; 168: 4018 – 24.en_US
dc.identifier.citedreferenceHolgate S, Peters-Golden M, Panettieri R, Henderson W. Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling. J Allergy Clin Immunol 2003; 111: S18 – S36.en_US
dc.identifier.citedreferenceWu A, Chik S, Chan A, Li Z, Tsang K, Li W. Anti-inflammatory effects of high-dose montelukast in an animal model of acute asthma. Clin Exp Allergy 2003; 33: 359 – 66.en_US
dc.identifier.citedreferenceBraccione F, Dorman S, O'Byrne P et al. The effect of cysteinyl leukotrienes on growth of eosinophil progenitors from peripheral blood and bone marrow of atopic subjects. J Allergy Clin Immunol 2002; 110: 96 – 101.en_US
dc.identifier.citedreferenceSpada C, Nieves A, Krauss A, Woodward D. Comparison of leukotriene B 4 and D 4 effects on human eosinophil and neutrophil motility in vitro. J Leukoc Biol 1994; 55: 183 – 91.en_US
dc.identifier.citedreferenceFregonese L, Silvestri M, Sabatini F, Rossi G. Cysteinyl leukotrienes induce human eosinophil locomotion and adhesion molecule expression via a cysLT1 receptor-mediated mechanism. Clin Exp Allergy 2002; 32: 745 – 50.en_US
dc.identifier.citedreferencePedersen K, Bochner B, Undem B. Cysteinyl leukotrienes induce P-selectin expression in human endothelial cells via a non-cysLT1 receptor-mediated mechanism. J Pharmacol Exp Ther 1997; 281: 655 – 62.en_US
dc.identifier.citedreferenceLee E, Robertson T, Smith J, Kilfeather S. Leukotriene receptor antagonists and synthesis inhibitors reverse survival in eosinophils of asthmatic individuals. Am J Respir Crit Care Med 2000; 161: 1881 – 6.en_US
dc.identifier.citedreferencePeters-Golden M, Bailie M, Marshall T et al. Protection from pulmonary fibrosis in leukotriene-deficient mice. Am J Respir Crit Care Med 2002; 165: 229 – 35.en_US
dc.identifier.citedreferenceTohda Y, Nakahara H, Kubo H, Haraguchi R, Fukuoka M, Nakajima S. Effects of ONO-1078 (pranlukast) on cytokine production in peripheral blood mononuclear cells of patients with bronchial asthma. Clin Exp Allergy 1999; 29: 1532 – 6.en_US
dc.identifier.citedreferenceNag S, Lamkhioued B, Renzi P. Interleukin-2-induced increased airways responsiveness and lung Th2 cytokine expression occur after antigen challenge through the leukotriene pathway. Am J Respir Crit Care Med 2002; 165: 1540 – 5.en_US
dc.identifier.citedreferenceHenderson W Jr, Tang L-O, Chu S-J et al. A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model. Am J Respir Crit Care Med 2002; 165: 108 – 16.en_US
dc.identifier.citedreferenceWang CT, Xu L, Martin J. Role of leukotriene D4 in allergen-induced increases in airway smooth muscle in the rat. Am Rev Respir Dis 1993; 148: 413 – 7.en_US
dc.identifier.citedreferencePanettieri R, Tan E, Ciocca V, Luttmann M, Leonard T, Hay D. Effects of LTD4 on human airway smooth muscle cell proliferation, matrix expression, and contraction in vitro: differential sensitivity to cysteinyl leukotriene receptor antagonists. Am J Respir Cell Mol Biol 1998; 19: 453 – 61.en_US
dc.identifier.citedreferenceIrvin C, Tu Y-P, Sheller J, Funk C. 5-Lipoxygenase products are necessary for ovalbumin-induced airway responsiveness in mice. Am J Physiol (Lung Cell Mol Physiol) 1997; 272: L1053 – 8.en_US
dc.identifier.citedreferenceHarizi H, Juzan M, Moreau J-F, Gualde N. Prostaglandins inhibit 5-lipoxygenase-activating protein expression and leukotriene B 4 production from dendritic cells via an IL-10-dependent mechanism. J Immunol 2002; 169: 139 – 46.en_US
dc.identifier.citedreferenceRobbiani D, Finch R, Jager D, Muller W, Sartorelli A, Randolph G. The leukotriene C 4 transporter MRP1 regulates CCL19 (MIP-3β, ELC)-dependent mobilization of dendritic cells to lymph nodes. Cell 2000; 103: 757 – 68.en_US
dc.identifier.citedreferenceHoshino M, Izumi T, Shimizu T. Leukotriene D 4 activates mitogen-activated protein kinase through a protein kinase Cα-Raf-1-dependent pathway in human monocytic leukemia THP-1 cells. J Biol Chem 1998; 273: 4878 – 82.en_US
dc.identifier.citedreferenceSaegusa S, Tsubone H, Kuwahara M. Leukotriene D 4 -induced rho-mediated actin reorganization in human bronchial epithelial cells. Eur J Pharmacol 2001; 413: 163 – 71.en_US
dc.identifier.citedreferenceThodeti C, Nielsen C, Paruchuri S, Larsson C, Sjolander A. The epsilon isoform of protein kinase C is involved in regulation of the LTD 4 -induced calcium signal in human intestinal epithelial cells. Exp Cell Res 2001; 262: 95 – 103.en_US
dc.identifier.citedreferenceStankova J, Rola-Pleszczynski M. Leukotriene B 4 stimulates c-fos and c-jun gene transcription and AP-1 binding activity in human monocytes. Biochem J 1992; 282: 625 – 9.en_US
dc.identifier.citedreferenceAnthonsen M, Andersen S, Solhaug A, Johansen B. Atypical λ/ι PKC conveys 5-lipoxygenase/leukotriene B 4 -mediated cross-talk between phospholipase A 2 s regulating NF-κB activation in response to tumor necrosis factor-α and interleukin-1β. J Biol Chem 2001; 276: 35344 – 51.en_US
dc.identifier.citedreferenceTomari S, Matsuse H, Machida I et al. Pranlukast, a cysteinyl leukotriene receptor 1 antagonist, attenuates allergen specific TNF-α production and NF-κB nuclear translocation in peripheral blood monocytes from atopic asthmatics. Clin Exp Allergy 2003; 33: 795 – 801.en_US
dc.identifier.citedreferenceCoffey M, Phare S, Peters-Golden M. Peroxynitrite-induced nitrotyrosination of proteins is blocked by direct 5-lipoxygenase inhibitor zileuton. J Pharmacol Exp Ther 2001; 299: 198 – 203.en_US
dc.identifier.citedreferenceEum S-Y, Maghni K, Hamid Q, Campbell H, Eidelman D, Martin J. Involvement of the cysteinyl-leukotrienes in allergen-induced airway eosinophilia and hyperresponsiveness in the mouse. Am J Respir Cell Mol Biol 2003; 28: 25 – 32.en_US
dc.identifier.citedreferenceBandeira-Melo C, Woods L, Phoofolo M, Weller P. Intracrine cysteinyl leukotriene receptor-mediated signaling of eosinophil vesicular transport-mediated interleukin-4 secretion. J Exp Med 2002; 196: 841 – 50.en_US
dc.identifier.citedreferenceDiamant Z, Grootendorst D, Vselic-Charvat M et al. The effect of montelukast (MK-0476), a cysteinyl leukotriene receptor antagonist, on allergen-induced airway responses and sputum cell counts in asthma. Clin Exp Allergy 1999; 29: 42 – 51.en_US
dc.identifier.citedreferenceSzefler S, Martin R, King T et al. Significant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol 2002; 109: 410 – 8.en_US
dc.identifier.citedreferenceStrauss L, Hejal R, Galan G, Dixon L, McFadden ER Jr. Observations on the effects of aerosolized albuterol in acute asthma. Am J Respir Crit Care Med 1997; 155: 454 – 8.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1365-2222.2003.01685.x.pdf
Size:
273.1KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.